EMA Outlines Methods for Transferring Product Approvals Before Brexit

International Pharmaceutical Regulatory Monitor
A A
The European Medicines Agency published new, practical guidance for marketing authorization holders in navigating the UK’s 2019 departure from the European Union — including the procedures for classifying any Brexit-related impacts on pharmaceutical manufacturing.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor